Adrenergic Signaling in Health and Disease

Dear Colleagues,

Adrenoceptors are central mediators in the sympathetic nervous system, triggering the body’s ability to react to acute stress. Cathecolamines, released under stress conditions, bind to and activate α₁-adrenoceptors, α₂-adrenoceptors, and β-adrenoceptors to mediate cell-specific responses to adrenergic stimuli. The role of adrenergic system has been widely associated with the regulation of cardiovascular functions, with α- and β-adrenoceptors displaying opposite activity and representing crucial therapeutic targets for cardiovascular diseases. However, a relevant role of adrenoceptors is also increasingly emerging in several other tissues and organs such as the brain, retina, lungs, adipose tissue, kidney, urinary bladder, etc., in which altered adrenoceptor function is involved in clinically relevant disorders. In this respect, targeting specific α- and β-adrenoceptors subtypes has also become the subject of interest for the treatment of neurological, respiratory, metabolic, and urologic conditions. Novel insights into the α- and β-adrenoceptor signaling, and the relative ligands selectivity and specificity, represent the new frontier for the characterization of adrenergic system function from systemic to cell-specific levels in health and disease.

This Special Issue aims at providing a comprehensive overview of recent findings, broadening the knowledge on the adrenoceptor system and its potential role in physiology and disease. In particular, we invite you to provide original research articles investigating novel mechanistic insights into adrenoceptor function, as well as to summarize the current state of the art. Manuscripts providing translational value will be particularly welcome.

Prof. Paola Bagnoli
Guest Editor
Dr. Rosario Amato
co-Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• animal models
• sympathetic regulation
• adrenoceptor-associated diseases
• adrenoceptor localization and function
• signaling pathways
• potential ligands